All Type of News
Pharmaceutical Firms Receive Penalties for Various Violations
Based on the 4th quarter 2004 pharmaceutical inspection report by Kyungin Regional Korea Food and Drug Administration (RKFDA), many of major domestic pharmaceutical firms received administrative penalties for a variet...
NHIC Expands Health Insurance Discount Provision
The National Health Insurance Corporation (NHIC) announced on February 2nd that the current National Health Insurance (NHI) contribution discount is being revised to further assist low-income families and those in the...
Cellbiotech Introduces Novel Anti-Hyperlipidemic Agent
Cellbiotech Co., a domestic biotechnology venture company, announced this week that it has successfully completed a pre-clinical animal study for a novel anti-hyperlipidemic agent known as PROLAC-T.
Jointly perform...
Health Ministry Suggests Centralized Licensing Control for Foreign Invested Healthcare Facilities
The Ministry of Health and Welfare (MOHW) made a suggestion earlier this week that the central government office should take control of licensing the foreign invested medical hospitals and other healthcare facilities ...
Uncertainty Arises for Proposed Pharmaceutical Law Reform Bill
In light of the February 1st opening of the National Assembly extra session, the pharmaceutical industry is giving its close attention to the proposed reform bill on the Korea Pharmaceutical Affairs Law, covering the ...
KPA Identifies Specific Manufacturers Showing Lack of Support Toward Inventory Return Request
The Korea Pharmaceutical Association (KPA) recently released a list of specific pharmaceutical manufacturers that are deemed as either non-responsive or non-supportive to the proposed return of cumulative surplus drug...
Kolon Wellcare to Expand W-Store Retail Outlets
Kolon Wellcare, the distribution unit of the Kolon group, plans to expand its franchise business of W-Store, a retail chain pharmacy designed and operated under a well-being concept, where the customers could purchase...
Velcade, Novel Anticancer Treatment, Now Available Under NHI Coverage
Janssen Korea announced this week that the company has completed the registration of Velcade (bortezomib) injection, a novel anticancer treatment, to the National Health Insurance (NHI) list of approved medications, a...
Government Imposes Regulatory Requirement on Drug Safety Device and Packaging
The government recently made an official announcement of approved regulatory revisions governing the Drug Safety Device and Packaging guidelines as specified under the Korea Pharmaceutical Affairs Law.
The approved...
Proposal for Regulatory Amendments for Corporate Pharmacies Submitted for Review
The proposal for regulatory amendments surrounding an establishment of corporate pharmacy entities was submitted to the national assembly on February 1st, where the major revision item is to permit the corporate entit...
